VEGFA and breast carcinoma: EGCG also inhibited the activation of hypoxia-inducible factor-1 (HIF-1α), nuclear factor kappa B (NF-κB), and vascular endothelial growth factor (VEGF) expression, resulting in the suppression of angiogenesis and breast cancer progression [36].